Cervical Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part and have signed a consent form agreeing to join the study.
- Your cervical cancer has been confirmed by a tissue sample (biopsy) as one of these types: squamous cell carcinoma, adenocarcinoma, or adenosquamous cell carcinoma.
- Your cancer is at a specific stage (classified as IB3, IIA2, IIB, IIC, IIIA, IIIB, IIIC, or IVA using the FIGO 2018 system) — confirm the exact stage with the trial site.
- You are generally well enough to carry out light activity and care for yourself (based on a standard fitness scale scored 0 or 1).
- Your doctors expect you to live for more than 6 months.
- If you are able to become pregnant, you must have had a negative pregnancy test within the past 7 days and agree to use contraception throughout the trial.
Who may not be able to join:
- You currently have a serious infection that is active or not under control.
- You have liver cirrhosis or another serious liver condition that is not well managed.
- You have a history of immune system problems, including HIV, or were born with an immune deficiency condition.
- You have chronic kidney problems or kidney failure.
- You have been diagnosed with another cancer within the last 5 years, or currently need treatment for another cancer.
- You have had a heart attack, a serious irregular heartbeat, or moderate-to-severe heart failure.
- Scans (CT, MRI, or PET-CT) show that lymph nodes near your main abdominal artery (para-aortic lymph nodes) are affected by cancer.
- You have previously had a procedure to block the arteries in your pelvis (pelvic artery embolization).
- You have previously had radiation therapy to your pelvic area.
- You have previously had part or all of your uterus surgically removed.
- You have had a severe allergic reaction to platinum-based chemotherapy drugs (such as cisplatin or carboplatin) in the past.
- You are taking medication for another condition (such as tuberculosis) that seriously affects how your liver or kidneys work (confirm with trial site).
- You are unable to understand the study plan or are unwilling to sign the consent form.
- You have another illness or condition that could seriously harm your health or affect how the trial runs (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dongling Zou, M.D., Chongqing University Cancer Hospital
Phone: 13657690699
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.